It is important for SMARCA4 to be intact in oncogene-driven lung adenocarcinomas, as loss of SMARCA4 dampens the KRAS signaling in a KRAS-addicted cancer and, subsequently, impairs proliferation of the tumor cells. The gene discussed is KRAS; the disease is lung adenocarcinoma.